|
|
|
| Advances in anti-inflammatory mechanism of berberine |
| LI Hongmei1 DANG Wantai2，3 YANG Xiaohong1 |
1.Department of Microbiology and Immunology, North Sichuan Medical College, Sichuan Province, Nanchong 637000, China;
2.Institute of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, Nanchong 637000, China; 3.Department of Rheumatology, Second Clinical Medical College, North Sichuan Medical College, Sichuan Province, Nanchong 637000, China |
|
|
|
|
Abstract Berberine is an isoquinoline alkaloid. It was used as a broad-spectrum antimicrobial agent in the clinical treatment of pseudomembranous enteritis, chronic gastritis, peptic ulcer and pneumonia. In recent years, with the pharmacological effects of berberine research, its anti-inflammatory mechanism has gradually become a hot research. In this paper, the clinical anti-inflammatory mechanism and research status of berberine in recent years were briefly reviewed, which provided the theoretical basis for the anti-inflammatory mechanism of berberine.
|
|
|
|
|
|
[1] 肖培根，肖伟，许利嘉，等.黄连及含小檗碱类生物碱的中草药[J].中国现代中药，2016（11）：1381-1385.
[2] Zou K，Li Z，Zhang Y，et al. Advances in the study of berberine and its derivatives：a focus on anti-inflammatory and anti-tumor effects in the digestive system [J]. Acta Pharmacol Sin，2017，38（2）：157-167.
[3] Cicero AF，Baggioni A. Berberine and its role in chronic disease [J]. Adv Exp Med Biol，2016，928：27-45.
[4] Halvorsen B，Santilli F，Scholz H，et al. LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro [J]. Diabetologia，2016，59（10）：2134-2144.
[5] Dain A，Repossi G，Diaz-Gerevini GT，et al. Long chain polyunsaturated fatty acids（LCPUFAs）and nordihydroguaiaretic acid（NDGA）modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model （Stillman Salgado rats）[J]. Lipids Health Dis，2016，15（1）：205.
[6] Singh K，Agrawal NK，Gupta SK，et al. Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus （T2DM） cases with impaired wound healing [J]. J Diabetes Complications，2016， 30（1）：99-108.
[7] Xie X，Chang X，Chen L，et al. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling [J]. Mol Cell Endocrinol，2013，381（1-2）：56-65.
[8] Zhao Y，Tang Z，Zhu X，et al. TAB3 involves in hepatic insulin resistance through activation of MAPK pathway [J]. Gen Comp Endocrinol，2015，224：228-234.
[9] 贾燕珺，李建军.小檗碱的抗动脉粥样硬化作用及其机制[J].中国动脉硬化杂志，2013，21（4）：364-368.
[10] Feng M，Zou Z，Zhou X，et al. Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE-/- mice [J]. Int Immunopharmacol，2017，43：195-202.
[11] Li H，He C，Wang J，et al. Berberine activates peroxisome proliferator-activated receptor gamma to increase athero?鄄sclerotic plaque stability in Apoe-/- mice with hyperhomocysteinemia [J]. J Diabetes Investig，2016，7（6）：824-832.
[12] Blaschke F，Bruemmer D，Law RE. Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis [J]. Rev Endocr Metab Disord，2004，5（3）：249-254.
[13] Liang KW，Ting CT，Yin SC，et al. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury [J]. Biochem Pharmacol，2006，71（6）：806-817.
[14] 张仁霞，傅永锦，梁基智，等.小檗碱治疗大鼠免疫复合性溃疡性结肠炎及下调炎性细胞因子作用[J].临床医学工程，2014（11）：1406-1409.
[15] Li YH，Xiao HT，Hu DD，et al. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses [J]. Pharmacol Res，2016，110：227-239.
[16] Li C，Xi Y，Li S，et al. Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation [J]. Mol Immunol，2015，67（2 Pt B）：444-454.
[17] Choe JY，Jung HY， Park KY，et al. Enhanced p62 expression through impaired proteasomal degradation is involved in caspase-1 activation in monosodium urate crystal-induced interleukin-1b expression [J]. Rheumatology（Oxford），2014，53（6）：1043-1053.
[18] Terkeltaub R. What makes gouty inflammation so variable？[J]. BMC Med，2017，15（1）：158.
[19] 杨虹，杨小红，钟晓武，等.辅助性T细胞17/调节性T细胞平衡在原发性痛风性关节炎发病机制中的作用[J].中华风湿病学杂志，2016，20（8）：520-525.
[20] Rock KL，Kataoka H，Lai JJ. Uric acid as a danger signal in gout and its comorbidities [J]. Nat Rev Rheumatol，2013，9（1）：13-23.
[21] Liu YF， Wen CY，Chen Z，et al. Effects of Berberine on NLRP3 and IL-1beta expressions in monocytic THP-1 cells with monosodium urate crystals-induced inflammation [J]. Biomed Res Int，2016，2016：2 503 703.
[22] Noack M，Miossec P. Selected cytokine pathways in rheumatoid arthritis [J]. Semin Immunopathol，2017，39（4）：365-383.
[23] Malemud CJ. Negative regulators of JAK/STAT signaling in rheumatoid arthritis and osteoarthritis [J]. Int J Mol Sci，2017，18（3）：484.
[24] Wang Z，Chen Z，Yang S，et al. Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects [J]. Inflammation，2014，37（5）：1789-1798.
[25] Huang M，Jiang X，Liang Y，et al. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease [J]. Exp Gerontol，2017，91：25-33.
[26] Yang Y，Wang Q，Xie M，et al. Berberine exerts an anti-inflammatory role in ocular Behcet's disease [J]. Mol Med Rep，2017，15（1）：97-102.
[27] Choi SB，Bae GS，Jo IJ，et al. Berberine inhibits inflammatory mediators and attenuates acute pancreatitis through deactivation of JNK signaling pathways [J]. Mol Immunol，2016，74：27-38.
[28] Caliceti C，Franco P，Spinozzi S，et al. Berberine：new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders [J]. Curr Med Chem，2016，23（14）：1460-1476.
[29] Wang X，He X，Zhang CF，et al. Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthritis in rats [J]. Biomed Pharmacother，2017，89：887-893. |
|
|
|
